Scarica l'app Stockscreener
6.055
1.46%
-0.09
Dopo l'orario di chiusura:
6.05
-0.005
-0.08%
Precedente Chiudi:
$6.145
Aprire:
$6.06
Volume 24 ore:
154.23K
Relative Volume:
0.03
Capitalizzazione di mercato:
$3.64M
Reddito:
$5.66M
Utile/perdita netta:
$-15.88M
Rapporto P/E:
-0.5352
EPS:
-11.3134
Flusso di cassa netto:
$-10.93M
1 W Prestazione:
-23.64%
1M Prestazione:
-37.90%
6M Prestazione:
+54.46%
1 anno Prestazione:
+117.81%
Intervallo 1D:
$5.90
$6.235
Intervallo di 1 settimana:
$5.90
$8.00
Portata 52W:
$0.3252
$20.35
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Nome
Bioaffinity Technologies Inc
Settore
Industria
Telefono
210-698-5334
Indirizzo
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
6.055 | 4.76M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
654.80 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
214.06 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
410.35 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.78 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
258.21 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
bioAffinity Technologies, Pictor Partner on Asthma and COPD Diagnostics - Medical Product Outsourcing
bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance UK
bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL - biospace.com
Shares could be offered up to 35% below market; bioAffinity Technologies (BIAF) seeks a stockholder vote. - Stock Titan
bioAffinity Technologies Builds Momentum for Non-Invasive Lung Cancer Detection - Yahoo Finance
2 visionary stocks built for the long term | 2026-09-28 | Investing News - Stockhouse
Price to book forward of bioAffinity Technologies, Inc. – NASDAQ:BIAF - TradingView
BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill
BIAF Historical Stock Prices & Daily Price Data | bioAffinity Technologies, Inc. Common - Quiver Quantitative
BIAF Forecast & Price Target - TradingKey
bioAffinity Technologies, Inc. (BIAF) Stock Price, News, Quote & History - Yahoo! Finance Canada
bioAffinity Technologies, Inc. (BIAF) Latest Stock News & Headlines - Yahoo! Finance Canada
bioAffinity Technologies to Showcase Lung Cancer Test Data at Veterans’ Research Conference - Yahoo Finance
bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference - biospace.com
Form 8K bioAffinity Technologies Inc For: 22 September By Investing.com - Investing.com Nigeria
Form 8K bioAffinity Technologies Inc For: 22 September - Investing.com India
BIAFW | bioAffinity Technologies, Inc. Warrant Insider Trading - Quiver Quantitative
BIAF Stock Soars As Hong Kong Patent Ignites Trading - StocksToTrade
BIAF Stock Soars As Hong Kong Patent Ignites Momentum - StocksToTrade
bioAffinity Technologies jumps 63% on Hong Kong lung cancer screening patent - mugglehead.com
EMA 20 stable that’s mean wanna shoot up🫴🏻😋 - Moomoo
BIAF stock jumps on Hong Kong patent news, with recent low-float dynamics likely adding to volatility - Quiver Quantitative
BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant - TradingView
Top Midday Gainers - Moomoo
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
bioAffinity Technologies Secures Hong Kong Patent for CyPath Lung Cancer Diagnostic - Yahoo Finance
bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic - BioSpace
BIAF Stock Draws Traders As Nasdaq Compliance And VA Deal Align - timothysykes.com
BIAF Stock Draws Traders As Nasdaq Compliance And Federal Deal Align - timothysykes.com
What’s Behind bioAffinity Technologies (NASDAQ:BIAF) Volume Surge? - Kalkine Media
bioAffinity Technologies at H.C. Wainwright conference: lung test gains traction - Investing.com Canada
BioAffinity Technologies (NASDAQ: BIAF) Announces Presentation Materials for 2026 H.C. Wainwright Global Investment Conference - Kalkine Media
Why Did bioAffinity (NASDAQ:BIAF) Regain Nasdaq Compliance? - Kalkine Media
bioAffinity Regains Nasdaq Compliance, Maintains Capital Market Listing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
bioAffinity Technologies shares rise after Nasdaq compliance update - Quiver Quantitative
Monday's Gap-Up and Gap-Down Stock Movers: September 8 - ChartMill
BIAF Stock Jumps As Federal Deal Fuels CyPath Lung Momentum - timothysykes.com
bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView
BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade
Congrats to the folks who joined at $10. Don't forget to give me a like 😘 - Moomoo
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Technologies, Inc. SEC Filing (Sep 8, 2026) - Stock Titan
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Trending Stocks Today | BioAffinity Technologies Shoots up 56.75% - Moomoo
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - StocksToTrade
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
BIAF News | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
bioAffinity Technologies to Present Corporate Update at Conference - The Globe and Mail
Bioaffinity Technologies Inc Azioni (BIAF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):